Status:
RECRUITING
Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders
Lead Sponsor:
Centre Hospitalier Intercommunal Robert Ballanger
Conditions:
Autism Spectrum Disorder (ASD)
Eligibility:
All Genders
3-15 years
Phase:
NA
Brief Summary
Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interaction...
Detailed Description
Currently, managing children with ASD emphasizes compensating for communication and social interaction disabilities. Communication tools like PECS or Makaton and social skills groups have shown effect...
Eligibility Criteria
Inclusion Criteria:
- Children aged 3 to 15 years.
- Clinically confirmed ASD by a psychiatrist.
- Parental or legal guardian consent for participation.
- Child showing a strong interest in screens and/or video content.
- Ability to tolerate the presence of other children.
- Minimum of 18 video drama sessions.
- Not having benefited from disease care in the past.
- Affiliation to a social security system
Exclusion Criteria:
- No ASD diagnosis.
- Younger than 3 or older than 15 at the study start.
- No interest in screens or video content.
- Parental or legal guardian refusal for participation.
- Dropping out before completing 18 sessions.
- Patient having benefited a disease care in the past
Key Trial Info
Start Date :
December 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 4 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06443320
Start Date
December 4 2023
End Date
March 4 2027
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHI Robert Ballanger
Aulnay-sous-Bois, France, 93600